Phenex Pharmaceuticals Aktiengesellschaft
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.phenex-pharma.com
Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2016-09-29
- Lead Sponsor
- Phenex Pharmaceuticals AG
- Target Recruit Count
- 12
- Registration Number
- NCT01999101
- Locations
- 🇦🇹
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Vienna, Austria
Multiple Ascending Oral Dose Phase I Study With Px-102
- First Posted Date
- 2013-12-02
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Phenex Pharmaceuticals AG
- Target Recruit Count
- 42
- Registration Number
- NCT01998672
- Locations
- 🇩🇪
FOCUS Clinical Drug Development GmbH, Neuss, Germany
Single Ascending Oral Dose Phase I Study With Px-102
- First Posted Date
- 2013-12-02
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Phenex Pharmaceuticals AG
- Target Recruit Count
- 54
- Registration Number
- NCT01998659
- Locations
- 🇩🇪
FOCUS Clinical Drug Development GmbH, Neuss, Germany
© Copyright 2025. All Rights Reserved by MedPath